Diabetes, Alzheimer’s Top 2 Areas for Drug Research

Diabetes, Alzheimer’s Top 2 Areas for Drug Research

Diabetes, Alzheimer’s, arthritis and heart disease top the list for the most new drugs in development to treat the common chronic diseases of older Americans, according to a new drug- industry report.

The report, by the Pharmaceutical Research and Manufacturers of America (PhRMA), an industry trade association, says 435 medicines that primarily target seniors are currently either in clinical trials or under review by the Food and Drug Administration (FDA).

Diabetes drugs are the largest chunk, at 110 potential new medications, followed by 67 for Alzheimers, 62 for arthritis and 61 for heart disease. The numbers are a drop from last year, when 142 diabetes drugs were in development, arthritis had 92 and Alzheimers had 82.

Read more by clicking here: http://bit.ly/1p9WpfF